First Time Loading...

ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 1.08 USD -6.09% Market Closed
Updated: May 5, 2024

ABVC Biopharma Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABVC Biopharma Inc
Operating Income Peer Comparison

Comparables:
AMGN
ALNY
KRTX
MRNA
SRPT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ABVC Biopharma Inc
NASDAQ:ABVC
Operating Income
-$8.2m
CAGR 3-Years
1%
CAGR 5-Years
-24%
CAGR 10-Years
-70%
Amgen Inc
NASDAQ:AMGN
Operating Income
$8.2B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
3%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Operating Income
-$282.2m
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
-12%
Karuna Therapeutics Inc
NASDAQ:KRTX
Operating Income
-$494.8m
CAGR 3-Years
-90%
CAGR 5-Years
-103%
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Operating Income
-$4.2B
CAGR 3-Years
-77%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Sarepta Therapeutics Inc
NASDAQ:SRPT
Operating Income
-$94.8m
CAGR 3-Years
46%
CAGR 5-Years
25%
CAGR 10-Years
0%

See Also

What is ABVC Biopharma Inc's Operating Income?
Operating Income
-8.2m USD

Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Operating Income amounts to -8.2m USD.

What is ABVC Biopharma Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-70%

Over the last year, the Operating Income growth was 46%. The average annual Operating Income growth rates for ABVC Biopharma Inc have been 1% over the past three years , -24% over the past five years , and -70% over the past ten years .